Nanexa AB (OSTO:NANEXA) Long-Term Debt : kr1.83 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Long-Term Debt?

Nanexa AB's Long-Term Debt for the quarter that ended in Mar. 2024 was kr1.83 Mil.

Nanexa AB's quarterly Long-Term Debt declined from Sep. 2023 (kr2.42 Mil) to Dec. 2023 (kr2.09 Mil) and declined from Dec. 2023 (kr2.09 Mil) to Mar. 2024 (kr1.83 Mil).

Nanexa AB's annual Long-Term Debt increased from Dec. 2021 (kr2.57 Mil) to Dec. 2022 (kr4.07 Mil) but then declined from Dec. 2022 (kr4.07 Mil) to Dec. 2023 (kr2.09 Mil).

Nanexa AB Long-Term Debt Historical Data

The historical data trend for Nanexa AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Long-Term Debt Chart

Nanexa AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

3.89

2.85

2.57

4.07

2.09

Nanexa AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															3.52	2.97	2.42	2.09	1.83

Nanexa AB (OSTO:NANEXA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nanexa AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanexa AB (OSTO:NANEXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Virdings Alle 32B, Uppsala, SWE, 75450

Website

https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB (OSTO:NANEXA) Headlines

No Headlines